Abstract:
The disclosed embodiments of the inventions disclosed in this application develop a 'protection' electric, magnetic or electromagnetic field or fields which are either superimposed upon an ambient field which is detrimental to the health of living systems, or is incorporated into the electrical circuit of the device which is generating the detrimental field. Either arrangement is successful in 'confusing' living cells, and thereby reducing the harmful effects of the otherwise detrimental field.
Abstract:
A method of isolating, purifying and recrystallizing substantially pure lutein, preferably from saponified marigold oleoresin through use of a series of filtrations and water/alcohol washes to obtain crude lutein crystals. The crystals are dissolved in a halogenated organic solvent in which lutein is strongly soluble and then a second organic solvent in which lutein is only partially soluble. Upon cooling of the mixture lutein is recrystallized in a high purity and then filtered and dried under vacuum. The lutein crystals are of the formula:
Lutein in pure form may be used as an analytical standard, as a nutritional supplement for use as an antioxidant and an agent that may prevent cancer, heart disease, and eye disease such as cataracts and age-related macular degeneration, and as a color additive in human foods.
Abstract:
Described is an "artificial virus" (AV) programmed with biomolecules that can enter human cells and carry out precise human genome modification. The AVs comprise: at least one viral vector, such as bacteriophage T4; at least one therapeutic molecule, such as DNA, RNA, protein and their complex; and a lipid coating. Also described is a method of human genome modification, using such an AV, and a method of program such an AV.
Abstract:
Complex viruses are assembled from simple protein subunits by sequential and irreversible assembly. During genome packaging in bacteriophages, a powerful molecular motor assembles at the special portal vertex of an empty prohead to initiate packaging. An aspect of the invention relates to the phage T4 packaging machine being highly promiscuous, translocating DNA into finished phage heads as well as into proheads. Single motors can force exogenous DNA into phage heads at the same rate as into proheads and phage heads undergo repeated initiations, packaging multiple DNA molecules into the same head. This shows that the phage DNA packaging machine has unusual conformational plasticity, powering DNA into an apparently passive capsid receptacle, including the highly stable virus shell, until it is full. These features allow for the design of a novel class of nanocapsid delivery vehicles.